ERIN FRAZIER: Open Payments
NPI 1861068439 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,741 in 122 payments from 16 companies in 2025. Trend: 2023 $1,839 · 2024 $1,903 · 2025 $2,741
Food & beverage: $2,741
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $404 |
| Neurocrine BioSciences, Inc. | 11 | $328 |
| Vanda Pharmaceuticals Inc. | 10 | $328 |
| E.R. Squibb & Sons, L.L.C. | 11 | $294 |
| Alkermes, Inc. | 13 | $255 |
| Teva Pharmaceuticals USA, Inc. | 11 | $237 |
| Otsuka America Pharmaceutical, Inc. | 12 | $176 |
| ABBVIE INC. | 12 | $175 |
| Janssen Pharmaceuticals, Inc | 7 | $167 |
| Axsome Therapeutics, Inc. | 9 | $153 |
Products named: CAPLYTA, INGREZZA, FANAPT, COBENFY, VRAYLAR, ARISTADA, Auvelity, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
